To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes.
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Stretching Entity Resources for Vulnerable Communities Act or the SERV Communities Act This bill makes a series of changes to the 340B drug pricing program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers), including alterations relating to program integrity, discrimination against participating entities, and program eligibility.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Administrative law and regulatory proceduresAdministrative remediesCivil actions and liabilityDrug, alcohol, tobacco useFraud offenses and financial crimesGovernment studies and investigationsHealth care costs and insuranceHealth facilities and institutionsHealth information and medical recordsInflation and pricesManufacturingMedical ethicsMedicareMental healthPrescription drugs
To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes.
USA115th CongressHR-6071| House
| Updated: 6/14/2018
Stretching Entity Resources for Vulnerable Communities Act or the SERV Communities Act This bill makes a series of changes to the 340B drug pricing program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers), including alterations relating to program integrity, discrimination against participating entities, and program eligibility.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Administrative law and regulatory proceduresAdministrative remediesCivil actions and liabilityDrug, alcohol, tobacco useFraud offenses and financial crimesGovernment studies and investigationsHealth care costs and insuranceHealth facilities and institutionsHealth information and medical recordsInflation and pricesManufacturingMedical ethicsMedicareMental healthPrescription drugs